LogoFDA 510(k) Search
Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K061376
    Device Name
    EL-ANCA: ANTI-MPO, ANTI-PR3, ANTI-MPO AND ANTI-PR3
    Manufacturer
    THERATEST LABORATORIES, INC.
    Date Cleared
    2006-07-20

    (64 days)

    Product Code
    MOB
    Regulation Number
    866.5660
    Type
    Traditional
    Panel
    Immunology
    Reference & Predicate Devices
    N/A
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    TheraTest EL- ANCATM: anti-MPO- and EL- ANCA™: anti-PR3 are intended for use in clinical laboratories as in vitro diagnostic tests for the detection and measurement of autoantibodies in human serum directed against human neutrophil myeloperoxidase and proteinase 3, respectively. Measurement of anti-MPO aids in the diagnosis of microscopic polyangiitis. Measurement of anti-PR3 aids in the diagnosis of Wegener's granulomatosis.

    Device Description

    Not Found

    AI/ML Overview

    I am sorry, but the provided document describes a 510(k) premarket notification for "TheraTest EL-ANCA™" devices, which are in vitro diagnostic tests. The document is a letter from the FDA determining substantial equivalence to predicate devices. It outlines the intended use of the devices for detecting and measuring autoantibodies.

    However, the document does not contain information on:

    • Acceptance criteria and reported device performance in a table format.
    • Sample sizes for test sets, data provenance, number of experts, their qualifications, or adjudication methods for establishing ground truth.
    • Information about multi-reader, multi-case (MRMC) comparative effectiveness studies or standalone algorithm performance.
    • The type of ground truth used (e.g., expert consensus, pathology, outcomes data).
    • Sample size for the training set or how ground truth for the training set was established.

    This document primarily focuses on the regulatory clearance of the device based on substantial equivalence, rather than detailed performance study design and results that would typically include the requested information.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1